{
  "id": "PD_CNS_STIMULATION_ADDITIVE",
  "name": "Additive CNS stimulation with multiple stimulants",
  "domain": "PD",
  "severity": "major",
  "rule_class": "avoid",
  "actions": [
    "Avoid combining multiple CNS stimulants unless clinically necessary.",
    "Monitor for psychomotor agitation, tremors, hyperreflexia, and insomnia.",
    "Assess for lowered seizure threshold and neuropsychiatric symptoms (e.g., mania or paranoia).",
    "Inquire about intake of non-prescription stimulants like high-dose caffeine or nicotine."
  ],
  "logic": {
    "pd_overlap": { 
      "effect_id": "CNS_stimulation", 
      "min_magnitude": "medium" 
    },
    "rationale": [
      "Simultaneous use of multiple agents increases excitatory neurotransmission in the brain.",
      "Combined CNS stimulation significantly raises the risk of behavioral toxicity and neurological adverse events."
    ]
  },
  "explanation_template": "{A_name} and {B_name} both possess CNS stimulant properties. Their concurrent use may lead to additive excitatory effects, increasing the risk of severe anxiety, insomnia, tremors, and potentially lowering the seizure threshold.",
  "references": [
    { 
      "source": "Educational note", 
      "citation": "PD stacking: shared CNS stimulation domain implies additive excitatory neuropharmacological effects." 
    }
  ]
}